metaSysX

Potsdam, Germany

Biotech Research, Evidence & Knowledge Diagnostics & Monitoring

metaSysX GmbH, a metabolomics and systems biology company, is a spinoff from the Max Planck Institute of Molecular Plant Physiology (MPIMP), Potsdam-Golm, Germany located in the GO:IN Incubator next to the Max Planck Institute. The founding of metaSysX was induced by the increasing demand of industry for a competent and comprehensive fee-for-service in the field of metabolomics, systems integration and mathematical modeling. metaSysX offers one of the most comprehensive metabolomics technologies worldwide directly mirroring leading edge metabolomics platforms developed for academic research at the MPIMP in the group of Prof. Dr. Lothar Willmitzer. In addition metaSysX offers comprehensive data analysis and integration with genetic, omics (transcriptomics) or other phenotypic data ranging from comprehensive statistical analysis to hand-tailored computational data analysis and mathematical modelling.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out metaSysX on @MedStartr Today #AllTherapeuticAreas #Biotech #ResearchEvidenceKnowledge #DiagnosticsScreeningMonitoring #MedMo #MedStartrVentures

https://www.medstartr.ai/s/5wNUedqFA6s

Get Involved in metaSysX

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2009
Website: metasysx.com/

Disease Areas

All Therapeutic Areas

Technologies

MetabolomicsBiotechnology

🌐Website

What do you think of metaSysX?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.